Skip to main content
SpringerLink
Log in

Characteristic Chromosomal Aberrations in Sporadic Cerebellar Hemangioblastomas Revealed by Comparative Genomic Hybridization

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Hemangioblastomas (HBs) of the central nervous system are benign tumors and occur as sporadic (sp) tumors (75%) or as a manifestation of the von Hippel-Lindau (VHL) disease (25%). VHL-disease is an autosomal dominant disorder characterized by HBs of the central nervous system and retina, renal cell carcinoma (RCC), phaeochromocytoma (PHEO), islet tumors of the pancreas, and endolympatic sac tumors as well as cysts and cystadenoma in the kidney, pancreas and epididymis. In VHL patients a large spectrum of germline mutations in the VHL gene has been detected. In spHBs VHL alleles are reported to be inactivated in up to 50% of the tumors. To our knowledge the involvement of other genes in spHBs has not been investigated. To elucidate the oncogenesis of spHBs, we performed CGH on 10 spHBs to screen for chromosomal imbalances throughout the entire tumor genome. Aberrations most frequently detected are losses of chromosomes 3 (70%), 6 (50%), 9 (30%), and 18q (30%) and a gain of chromosome 19 (30%). Based on these frequencies and the co-occurrence of these aberrations in the analyzed tumors we hypothesize that loss of chromosome 3 (harboring the VHL gene) is an early event in the oncogenesis of spHBs, followed by loss of 6, and then losses of chromosomes 9, 18q and gain of chromosome 19. Comparison of the chromosomal imbalances in spHBs to those previously reported in RCCs and PHEOs reveals that the pathway of spHBs shows similarities to both the RCCs and PHEOs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Burger PC, Scheithauer BW: Tumors of the central nervous system. In: Atlas of tumor pathology. Armed forces intitute of pathology, Washington, D.C., 1994

    Google Scholar 

  2. Kleiheus P, Cavenee WK: Pathology and genetics of tumours of the nervous system – World Health Organization classification of tumours, 1999

  3. McKusick VA: Mendelian inheritance in man: a catalogue of human genes and genetic disorders. The John Hopkins University Press, Baltimore & London 11th issue, 1994

    Google Scholar 

  4. Latif F, Tory K, Gnarra JR, Yoa M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan DR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Schmidt MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317–1320, 1993

    Google Scholar 

  5. Kanno H, Kondo K, Ito S, Yamamoto I, Fujii S, Torigoe S, Sakai N, Hosaka M, Yao M: Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas. Cancer Res 54: 4845–4847, 1994

    Google Scholar 

  6. Oberstrass J, Reifenberger G, Reifenberger J, Wechsler W, Collins VP: Mutations of the von Hippel-Lindau tumor suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol 179: 151–156, 1996

    Google Scholar 

  7. Lee J, Dong S, Park W, Yoo N, Kim C, Jang J, Chi J, Zbar BLIA, Linehan WM, Vortmeyer AO, Zhuang Z: Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 58: 504–508, 1998

    Google Scholar 

  8. Glaskar S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann HPH: The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system. J Neurol Neurosurg Psychiatry 67: 758–762, 1999

    Google Scholar 

  9. Duan DR, Pause A, Burgess WH, Aso T, Chen DY, Garret KP, et al.: Inhibition of transcription elongation by the VHL tumor suppresor protein. Science 269(5229): 1402–1406, 1995

    Google Scholar 

  10. Pause A, Peterson B, Schaffar G, Stearma R, Klausner RD: Studying interactions of four proteins in the yeast twohybrid system: structural resemblance of the pVHL/elongin BC/hCUL-2 complex with the ubiquitin ligase complex SKP1/cullin/F-box protein. Proc Natl Acad SciUSA 96(17): 9533–9538, 1999

    Google Scholar 

  11. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman FM, Pinkel D: Comparitive Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors. Science 258: 818–821, 1992

    Google Scholar 

  12. du Manoir S, Speicher MR, Joos S, Schrock E, Popp S, Dohner H, Kovacs G, Robert-Nicoud M, Lichter P, Cremer T: Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet 90: 590–610, 1993

    Google Scholar 

  13. Presti JC, Moch H, Reuter VE, Cordon-Cardo C, Waldman F: Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis. J Urology 156: 281–285, 1996

    Google Scholar 

  14. Gronwald J, Strokel S, Holtgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, Lubinski J, Cremer T: Comparison of DNA gains and losses in primary renal clear cell carcinomas and metastatic sites: Importance of 1q and 3p copy number changes in metastatic events. Cancer Res 57: 481–487, 1997

    Google Scholar 

  15. Moch H, Presti JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ, Waldman FM: Genetic aberration detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56: 27–30, 1996

    Google Scholar 

  16. Edstrom E, Mahlamaki E, Nord B, Kjellman M, Karhu R, Hoog A, Goncharov N, Tean Teh B, Backdahl M, Larsson C: Comparative genomic hybridization reveals frequent losses of chromosome 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology. Am J Pathol 156: 651–659, 2000

    Google Scholar 

  17. Jeuken JWM, Sprenger SHE, Wesseling P, Macville MVE, von Deimling A, Teepen HLJM, van Overbeeke JJ, Boerman RH: Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 58: 606–612, 1999

    Google Scholar 

  18. Miller SA, Dykes DD, Polsky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 16: 1215, 1988

    Google Scholar 

  19. Schraml P, Zhaou M, Richter J, Brunning Th, Pommer M, Sauter G, Mihatsch MJ, Moch H: Analysis of Renal Tumors in Trichloroethylene-exposed Workers by Comparative Genomic Hybridisation and DNA Sequencing analysis. Verhandlungen der Deutschen Gesellschaft fur Pathologie 83: 218–224, 1999

    Google Scholar 

  20. Knuutila S, Aalto Y, Autio K, Bjorkqvist AM, El-Rafai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkannen M, Varis A, Wasenius VM, Wolf M, Zhu Y: DNA copy number losses in human neoplasms. Am J Pathol 155: 683–694, 1999

    Google Scholar 

  21. Olschwang S, Richard S, Boisson C, Giraud S, Laurent-Puig P, Resche F, Thomas G: Germline mutation profile of the VHL gene in von Hippel-Lindau disease and in sporadic heamangioblastoma. Human Mutation 12: 424–430, 1998

    Google Scholar 

  22. Tse JYM, Wong JHC, Lo K, Poon W, Huang D, Ng H: Molecular genetic analysis of the von Hippel-Lindau disease tumor suppressor gene in familial and sporadic cerebellar haemangioblastomas. Am J Clin Pathol 107: 459–466, 1997

    Google Scholar 

  23. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan DR, Gnarra JR, Linehan WM, Baylin SB: Silencing of the VHL tumor suppressor gene by DNA methylation in renal cell carcinoma. Proc Natl Acad Sci USA 91: 9700–9704, 1995

    Google Scholar 

  24. Richard S, David P, Marsot-Dupuch K, Giraud S, Beroud C, Resche F: Central nervous system haemangioblastomas, endolympatic sac tumors, and von Hippel-Lindau disease. Springer-Verlag 23: 1–22, 2000

    Google Scholar 

  25. Stratmann R, Krieg M, Haas R, Plate KH: Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene. J Neuropathol Exp Neurol 56: 1242–1252, 2000

    Google Scholar 

  26. Wizigmann-Voos S, Breier G, Risau W, Plate KH: Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and 247 sporadic hemangioblastomas. Cancer Res 55: 1358–1364, 1995

    Google Scholar 

  27. Bohling T, Turunen O, Jaaskelainen J, Carpen O, Saino M, Wahlstrom T, Vaheri A, Haltia M: Ezrin expression in stromal cells of capillary hemangioblastoma. Am J Pathol 148: 367–373, 1996

    Google Scholar 

  28. Knuutila S, Bjorkqvist AM, Autio K, Trakkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rafai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y: DNA copy number amplifications in human neoplasms. Am J Pathol 152: 1107–1123, 1998

    Google Scholar 

  29. Vortmeyer AO, Gnarra JR, Emmert-Buck MR, Katz D, Linehan WM, Oldfoeld EH, Zhuang Z: von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease. Hum Pathol 28: 541–543, 1997

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, University Medical Center Nijmegen, Nijmegen, The Netherlands

    Sandra H.E. Sprenger, Johanna M.M. Gijtenbeek, Pieter Wesseling, Martin Lammens & Judith W. M. Jeuken

  2. Department of Pathology, University Medical Center Nijmegen, Nijmegen, The Netherlands

    Pieter Wesseling

  3. Department of Pathology, University Hospital K.U, Leuven, Belgium

    Raf Sciot & Martin Lammens

  4. Department of Neurosurgery, University Hospital K.U, Leuven, Belgium

    Frank Van Calenbergh

Authors
  1. Sandra H.E. Sprenger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johanna M.M. Gijtenbeek
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pieter Wesseling
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raf Sciot
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Frank Van Calenbergh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Martin Lammens
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Judith W. M. Jeuken
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sprenger, S.H., Gijtenbeek, J.M., Wesseling, P. et al. Characteristic Chromosomal Aberrations in Sporadic Cerebellar Hemangioblastomas Revealed by Comparative Genomic Hybridization. J Neurooncol 52, 241–247 (2001). https://doi.org/10.1023/A:1010623119469

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1010623119469

Search

Navigation